Mr. Alan Tam reports

LIBERTY BIOPHARMA ANNOUNCE THE APPOINTMENT OF DR. MING FU CHIANG AS MEDICAL ADVISOR

Liberty Biopharma Inc. (a wholly owned subsidiary of Avapecia Life Sciences Corp. responsible for the worldwide marketing of the Avagenesis Corp. and Avapecia standardized adipose stem cell therapy isolation and enrichment platform) has appointed Dr. Ming Fu Chiang, MD, PhD, MBA, as medical adviser.

Dr. Chiang is an active neurosurgeon and the former vice-director of the department of surgery and former chairman of neurosurgery at Mackay Memorial Hospital in Taipei, Taiwan. He is also the former director of the Taiwan Society of Neurosurgery and the current journal reviewer for Stroke, Surgical Neurology, International Journal of Clinical Practice and Journal of Orthopedic Surgery and Research.

Dr. Chiang's main areas of research interest include the study of brain tumours, strokes, the molecular biology of the brain and the biomechanics of the spine. He has also written over 40 research publications in prestigious international journals.

We seek Safe Harbor.